Testosterone Replacement Therapy Insurance Denied? How to Appeal

Testosterone replacement therapy (TRT) is an established, FDA-approved treatment for hypogonadism — a clinical endocrine disorder in which the body fails to produce sufficient testosterone. Despite clear diagnostic criteria and decades of clinical evidence, TRT claims are denied at an alarming rate. Insurers routinely contest lab values, dispute the underlying diagnosis, or demand failed alternatives before authorizing treatment. If your TRT claim was denied, a well-documented appeal citing clinical guidelines and your specific diagnosis can often reverse that decision.

Why Insurers Deny Testosterone Replacement Therapy

Insurance companies use several overlapping strategies to deny TRT coverage, even when a physician has diagnosed hypogonadism and determined TRT is medically necessary.

Lab values do not meet the plan's threshold. Most insurers require at least two morning fasting serum testosterone measurements below a specific cutoff — commonly 300 ng/dL, though some plans use 200 ng/dL or lower. If your levels were measured at the wrong time of day, in a non-fasting state, or only once, the insurer may argue that hypogonadism has not been confirmed. The Endocrine Society Clinical Practice Guideline (2018) specifies that diagnosis requires two measurements on separate occasions, both performed before 10 AM.

Symptoms not adequately documented. Hypogonadism is a clinical syndrome, not a purely biochemical finding. Classic symptoms include low libido, fatigue, depressed mood, reduced muscle mass, increased body fat, poor concentration, reduced bone density, and erectile dysfunction. ICD-10 code E29.1 (testicular hypofunction) or E23.0 (hypopituitarism) must appear in physician notes alongside documented symptom burden. If your chart only records a lab value without clinical symptom documentation, the insurer can deny on grounds that treatment isn't clinically indicated.

Failure to identify and treat the underlying cause. Guidelines recommend distinguishing primary hypogonadism (testicular failure — elevated LH/FSH, low testosterone) from secondary hypogonadism (hypothalamic-pituitary dysfunction — low LH/FSH, low testosterone). Secondary causes may include hyperprolactinemia, pituitary tumors, opioid-induced hypogonadism, or other reversible conditions. If your workup didn't include LH, FSH, and prolactin levels alongside a complete history, the insurer may deny on grounds that evaluation was incomplete.

Age-related testosterone decline classified as non-pathological. Insurers frequently distinguish between normal age-related testosterone decline (sometimes called "low T") and clinical hypogonadism — a recognized endocrine disorder. Your documentation must establish a pathological diagnosis with ICD-10 coding, not merely low-normal levels in an aging patient.

Step therapy requirements. Some plans require lifestyle modification (weight loss, alcohol reduction, exercise) or treatment of contributing conditions (obesity, sleep apnea) before authorizing TRT. If your plan has step therapy requirements, document any prior efforts and explain why they were insufficient.

How to Appeal a TRT Denial

Step 1: Obtain the Denial Letter and Identify the Specific Reason

Request your complete denial in writing if you have not already received it. The denial must state the specific clinical criteria your claim failed to meet. Common citations include the plan's medical policy for hypogonadism, UpToDate criteria, or Endocrine Society guidelines. You must know exactly what threshold you allegedly failed to meet before crafting your response.

Step 2: Confirm Diagnostic Accuracy With Your Physician

Schedule a follow-up with your endocrinologist or urologist. Ensure your chart contains two documented morning fasting testosterone measurements, the complete hormonal workup (LH, FSH, prolactin, SHBG, free testosterone), and a detailed symptom assessment. The ICD-10 code on your claim should reflect your specific diagnosis — E29.1, E23.0, or another appropriate code — not an unspecified or non-pathological code.

Step 3: Gather Clinical Guideline Support

Your appeal letter should cite authoritative sources directly. The 2018 Endocrine Society Clinical Practice Guideline on Testosterone Therapy in Men with Hypogonadism provides the most widely accepted diagnostic and treatment criteria. If your plan's threshold is stricter than the guidelines, call out that discrepancy explicitly. FDA-approved TRT formulations (gels, injections, pellets, transdermal patches) all carry hypogonadism as the indicated condition.

Step 4: Obtain a Letter of Medical Necessity

Your physician should write a letter of medical necessity that documents your testosterone levels with dates and times of collection, your complete symptom burden, the ICD-10 diagnosis, the prior workup performed, any reversible causes investigated and addressed, and the specific TRT formulation requested with clinical rationale. This letter is the core of your appeal.

Step 5: Address Step Therapy Compliance

If the denial cited failure to complete step therapy, document any lifestyle interventions or treatments for contributing conditions attempted prior to TRT initiation. If your physician determined step therapy was medically inappropriate for your case (for example, because your testosterone deficiency is primary and unresponsive to lifestyle modification), the letter of medical necessity should explicitly state why.

Step 6: Submit the Internal Appeal and Request Peer-to-Peer Review

File your internal appeal within the deadline specified in your denial letter (typically 30–180 days). Request that your physician be granted a peer-to-peer review with the insurer's medical reviewer. Direct physician-to-physician conversations have a high rate of reversing denials, particularly when the treating physician can directly address the criteria gap.

What to Include in Your Appeal

• Two documented morning fasting testosterone lab results with collection times and ICD-10 diagnosis code (E29.1, E23.0, or applicable code)
• Complete hormonal panel results (LH, FSH, prolactin, SHBG, free testosterone)
• Physician letter of medical necessity documenting symptom burden, clinical diagnosis, and treatment rationale
• Citation of the 2018 Endocrine Society Clinical Practice Guideline on testosterone therapy
• Documentation of any step therapy compliance or physician justification for bypass
• Peer-to-peer review request from your treating endocrinologist or urologist

Fight Back With ClaimBack

Testosterone replacement therapy denials are among the most formulaic and reversible insurance decisions — insurers often apply rigid thresholds that don't account for the full clinical picture your physician has documented. ClaimBack generates a professional appeal letter in 3 minutes.

Start your free claim analysis →

Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal